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Maintaining quiescent cells in G0 phase is achieved in part through the multiprotein subunit complex known as DREAM, and in
human cell lines the transcription factor E2F4 directs this complex to its cell cycle targets. We found that E2F4 binds a highly
overlapping set of human genes among three diverse primary tissues and an asynchronous cell line, which suggests that tissue-
specific binding partners and chromatin structure have minimal influence on E2F4 targeting. To investigate the conservation of
these transcription factor binding events, we identified the mouse genes bound by E2f4 in seven primary mouse tissues and
a cell line. E2f4 bound a set of mouse genes that was common among mouse tissues, but largely distinct from the genes bound
in human. The evolutionarily conserved set of E2F4 bound genes is highly enriched for functionally relevant regulatory
interactions important for maintaining cellular quiescence. In contrast, we found minimal mRNA expression perturbations in
this core set of E2f4 bound genes in the liver, kidney, and testes of E2f4 null mice. Thus, the regulatory mechanisms maintaining
quiescence are robust even to complete loss of conserved transcription factor binding events.
Citation: Conboy CM, Spyrou C, Thorne NP, Wade EJ, Barbosa-Morais NL, et al (2007) Cell Cycle Genes Are the Evolutionarily Conserved Targets of the
E2F4 Transcription Factor. PLoS ONE 2(10): e1061. doi:10.1371/journal.pone.0001061
INTRODUCTION
Quiescence of cellular proliferation is crucial for mammalian tissue
homeostasis, and aberrant activation of cell cycle programs can
lead to cancer [1,2,3,4,5]. In mammalian cells, the highly
conserved, multi-subunit complex known as DREAM is princi-
pally responsible for inhibiting cellular proliferation [6,7,8], and
DREAM member homologs can be found in drosophila, worms,
and mammals [2,4,6,7,8,9,10,11,12]. The DREAM complex is
composed of multiple subunits with different functional roles; for
instance, the site-specific transcription factor E2F4 and the pocket
protein p130 serve to anchor the DREAM complex to direct
functional targets. Consistent with a global role in maintaining
quiescence, E2F4 has been shown to bind to and regulate a set of
proliferation and cell cycle related targets in a number of ex vivo
human cell lines, including glioblastoma [8,13], fibroblast [14],
and osteoblasts [15]. However, it is not known whether E2F4
controls similar genes in primary, quiescent human tissues, nor
whether these regulatory connections are conserved evolutionarily.
Removal of key E2F components of the multisubunit complexes
that control the cell cycle can cause aberrant activation of cellular
proliferation in specific tissues during development and in
adulthood reviewed in ([2], also [5]). For instance, homozygous
loss of E2f4 causes a dramatic reduction in erythropoiesis in fetal
mouse liver [16,17]. Gene expression analysis revealed broad,
substantial changes in transcription between developing erythro-
cytes lacking E2f4 and their wild-type counterparts [17]. The
tissue-restricted nature of this phenotype indicates the presence of
overlapping and partially redundant roles for other E2F
transcription factors [1,2,4,18,19,20]; for instance, it is known
that E2F5 and E2F6 can compensate for loss of E2F4 [21,22].
Despite wide fluctuations and evolutionary turnover of
transcription factor binding events between mouse and human
[23], it has been proposed that conserved genomic occupancy of
a transcription factor binding can enrich for functionally relevant
regulatory connections [24]. By comparing E2F4 DNA-binding
events among multiple primary tissues in human and mouse, we
uncovered a conserved set of regulatory interactions potentially
relevant to maintaining cellular quiescence. We further inspected
the tissue-specific gene expression programs in E2f4 null mice to
determine the transcriptional importance of E2f4 binding in
primary mouse tissues.
RESULTS
E2F4 binds a common set of cell cycle genes in
multiple primary human tissues
We identified the proximal promoter regions that E2F4 occupies
in three primary human tissues (hepatocytes, pancreatic acinar,
and pancreatic islets) directly isolated from donor organs, and an
asynchronous human cell line (HepG2), using chromatin immu-
noprecipitation and promoter microarrays representing 13,000
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promoter arrays targeted to transcription start sites capture the
large majority of E2F4-chromatin interactions in the genome
[8,14]; we confirmed this result using whole-chromosome arrays
that indicated that E2F4 binds largely at transcriptional start sites
within the human and mouse genomes (Figure S1). For each
tissue/species, assessment of genes bound by E2F4 was determined
using a corrected p-value derived from empirical Bayes and linear
model analysis across replicate microarrays for each gene [26]
(Materials and Methods).
On our array platform, we found that E2F4 binds approximately
500 to 700 human genes, depending on the tissue. Among all three
quiescent primary human tissues and the proliferating HepG2
carcinoma line, we observed overlap greater than 70% and as high
as 84% (Figure 2A, Figure S2). This overlap is similar to the overlap
previously observed between E2F4 bound genes in glioblastoma
T98G cells and osteosarcoma U2OS cells on different microarray
platforms under cell cycle arresting conditions [8]; our data capture
approximately75%ofthesametargetscompared withthedatafrom
references [8,15] (Materials and Methods).
A substantial majority of genes bound by E2F4 are bound in
most tissues; we identified a core set of approximately 450 genes
common to all human tissues in our study (Table 1, Figure S3,
Materials and Methods). These include prior known E2F4 targets,
including genes involved in cell cycle (CCNB1, INCENP, GSPT1,
CDC6) and DNA repair (BRCA1, EXO1, XRCC1) [8,13,14,15].
Analysis of gene ontology categories showed that cell cycle,
proliferation, and DNA repair genes are consistently over-
represented (Figure S3). Importantly, inspection of the tissue-
specific targets revealed no functional pathway enrichment (Figure
S4). We confirmed that the canonical E2F4 binding sequence was
highly enriched in the E2F4 bound promoter regions. Typically
we found 75% of the bound regions contained a known E2F4
binding sequence, compared with 35% among the unbound
promoters present on the human promoter microarray (Figure S5).
Taken together, our data indicate that, largely independent of the
particular tissue-specific nuclear environment, E2F4 binds to and
potentially regulates a similar set of human genes.
Genes bound by E2F4 in both mouse and human
capture cell cycle functional pathways
Because of the high conservation of the DREAM complex, we
expected to observe in mouse a pattern of E2F4 binding similar to
Figure 1. Strategy to compare E2F4 bound and E2F4 dependent gene expression in mouse and human. (A) Transcription factor binding was
identified in vivo using chromatin immunoprecipitation combined with proximal promoter arrays in three human tissues, a human cell line, seven
mouse tissues, and a mouse cell line. (B) Gene expression in the liver, kidney, and testes of littermate mice lacking one or two copies of E2f4 were
compared in replicate, and genes specifically perturbed in the adult identified in all three tissues. (C) Analysis approaches identified the genes bound
in common among all human and all mouse tissues, those shared between species, and whether any genes were both bound by E2f4 in mouse adult
liver, kidney, or testes, and whose expression were altered by removal of E2f4.
doi:10.1371/journal.pone.0001061.g001
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independent of the particular tissue, and enriched for pro-
liferation-related pathways. To test this hypothesis, we performed
E2f4 chromatin immunoprecipitations in seven primary mouse
tissues and a mouse cell line using promoter microarrays
representing 13,000 regions in the mouse genome (Figure 2B).
As with human, E2f4 binds approximately 500 to 700 genes, the
overlap between tissues is greater than 65% and as high as 85%
(Figure 2B, Figure S6); using p-value cutoff of 10
24, a core set of
approximately 450 genes are bound in common by E2f4 in all
mouse tissues (Figure S7). The genes bound by E2f4 show
functional pathway enrichment in cell cycle, proliferation, and
DNA repair, as expected (Figure 2D).
To test whether the mouse genes bound by E2f4 were largely
similar to those found in human, we identified the set of
homologous genes present on both arrays and compared the core
set of genes bound in each species (Figure 2C). To our surprise, we
found that most of the genes bound by E2F4 were highly species-
specific. Approximately 80% of the bound genes that had
homologs in the second species were uniquely bound in the first
species; only a fifth of the bound homologous genes shared E2F4
binding between species. Recent reports have indicated that
transcription factor binding is preferentially conserved when
a bound target gene is required for a transcriptional regulator’s
function [23]. Indeed, we determined that the genes bound in both
species were enriched in known E2F4 functional categories like cell
cycle control, proliferation, and DNA repair (Figure 2C). In-
terestingly, DNA packaging, which has been suggested to be
a function of E2F4 in murine cells [27], was enriched as
a functional category in the genes uniquely bound by E2f4 in
mouse (Figure 2D, Figure S7).
Gene expression programs in quiescent tissues can
recover from removal of E2f4 during development
We tested whether the mouse genes bound by E2f4 in liver,
kidney, and testes were dependent on the presence of E2f4 for
proper transcription. We compared the gene expression patterns
of these tissues in E2f4 null mice to those found in identical tissues
from E2f4 heterozygous littermates, which are phenotypically
normal. During development, E2f4 null mice have severe
disruption of liver-based erythropoiesis [17]. In addition, E2f4
null mice reproduce poorly, and this effect could be partially due
to misregulation of gene expression in testicular tissues. Finally,
kidney was chosen as a highly differentiated tissue that does not
appear to have substantial proliferative capacity, and does not
appear to be affected by removal of E2f4.
All three mouse tissues had surprisingly minor transcriptional
perturbations in the absence of E2f4. Specifically, E2f4 null mice
showed transcriptional perturbations among 10 genes in testes, 34
genes in liver, and 78 genes in kidney relative to heterozygous
littermates (Figure 3, Figure S8). The genes whose transcripts
showed changes in the absence of E2f4 were largely unique to each
tissue (Figure 3A), and little overlap was observed between genes
with altered expression and the genes bound by E2f4 in the same
tissues (Figure 3B). We further considered the possibility that the
E2f4-bound genes may show low-level gene expression changes
that would be detectable if considered as a set [28]. We found no
evidence of consistent up- or down-regulation in liver, kidney, or
testes using any gene set combination reported to date, including
the set of bound genes by E2f4 in mouse. In addition, the sets of
differentially expressed genes were not enriched in any functional
categories (not shown), and the promoters of these genes showed
neither enrichment in direct E2f4 occupancy (Figure 3A) nor
enrichment in the presence of E2f4 binding sequences
when compared with the DNA present on the promoter arrays
(Figure S4).
Altered transcripts in the E2f4 null mouse tissues represent the
final, stable result of compensation in mice that survive the
removal of E2f4, and as such would be expected to include both
direct and indirect E2f4 targets. Remarkably, the list of genes
bound by E2f4 in adult wild-type tissues did not appreciably
overlap with the genes whose transcription is perturbed by
complete loss of E2f4 (Figure 3). As described above, E2f4 binding
Figure 2. Genome-wide binding of E2F4 in mouse and human tissues.
(A) Fraction of overlap of human genes bound by E2F4 in liver,
pancreatic islets, pancreatic acinar, and HepG2 is shown as a grayscale
shaded graph. Fractions and shading are calculated relative to the
tissue with the fewest bound genes. The total number of binding
targets for each tissue is shown in white boxes. (B) Similar plot for the
overlap of mouse genes bound by E2f4 in liver, spleen, kidney, brain,
testes, pancreatic islets, pancreatic acinar, and Min6. (C) Overlap
between the mouse and human genes bound in common in all mouse
and human tissues where homologs exist between the species.
Consistent with previous results [23], the overlap is approximately
20%. (D) The genes bound by E2F4 in both mouse and human are
substantially enriched in genes accounting for E2F4 function.
doi:10.1371/journal.pone.0001061.g002
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..................................................................................................................................................
Selected genes (by category) bound by E2F4 in all human tissues p-value for E2F4 binding
Process Gene Full Name Liver Acinar Islets HepG2
Cell Cycle ZWINT ZW10 interactor 4.0E-08 6.0E-08 7.0E-08 4.0E-08
(1610–44) CCNB1 Cyclin B1 7.0E-08 9.0E-08 2.0E-07 8.0E-08
INCENP Inner centromere protein 2.0E-07 3.0E-07 3.0E-07 2.0E-07
CDC23 Cell division cycle 23 homolog 2.0E-06 3.0E-06 3.0E-06 1.0E-06
CDC6 Cell division cycle 6 homolog 5.0E-08 7.0E-08 9.0E-08 5.0E-08
CDK2 Cyclin-dependent kinase 2 4.0E-06 8.0E-06 5.0E-06 5.0E-06
NEK2 NIMA-related kinase 2 2.0E-05 3.0E-05 2.0E-05 2.0E-05
MAD2L1 MAD2 mitotic arrest deficient-like 1 5.0E-07 1.0E-06 9.0E-07 5.0E-07
CDC45L CDC45 cell division cycle 45-like 3.0E-07 5.0E-07 5.0E-07 3.0E-07
CCNB2 Cyclin B2 2.0E-08 2.0E-08 3.0E-08 3.0E-08
RBL1 Retinoblastoma-like 1 (p107) 3.0E-06 4.0E-06 4.0E-06 3.0E-06
NUDC Nuclear distribution gene C homolog 3.0E-05 4.0E-05 3.0E-05 3.0E-05
E2F3 E2F transcription factor 3 1.0E-05 1.0E-05 1.0E-05 1.0E-05
TCF19 Transcription factor 19 (SC1) 9.0E-07 2.0E-06 2.0E-06 7.0E-07
CCNG2 Cyclin G2 1.0E-07 1.0E-07 2.0E-07 1.0E-07
DNA Replication RFC3 Replication factor C (activator 1) 3 1.0E-06 2.0E-06 2.0E-06 9.0E-07
(4610–19) PCNA Proliferating cell nuclear antigen 2.0E-06 3.0E-06 3.0E-06 2.0E-06
POLE3 Polymerase epsilon 3 (p17 subunit) 2.0E-05 2.0E-05 2.0E-05 2.0E-05
NUP98 Nucleoporin 98 kDa 1.0E-05 2.0E-05 2.0E-05 2.0E-05
ORC3L Origin recognition complex, subunit 3-like 4.0E-07 5.0E-07 5.0E-07 3.0E-07
RRM1 Ribonucleotide reductase M1 polypeptide 2.0E-07 3.0E-07 3.0E-07 2.0E-07
ORC1L Origin recognition complex, subunit 1-like 7.0E-06 1.0E-05 1.0E-05 8.0E-06
TOP2A Topoisomerase (DNA) II alpha 8.0E-07 1.0E-06 1.0E-06 6.0E-07
RFC5 Replication factor C (activator 1) 5 2.0E-06 4.0E-06 4.0E-06 2.0E-06
BLM Bloom syndrome 7.0E-09 6.0E-09 4.0E-09 6.0E-09
DNA repair DCLRE1C DNA cross-link repair 1C (PSO2 homolog) 4.0E-07 6.0E-07 6.0E-07 4.0E-07
(8610–18) XRCC1 X-ray repair complementing defective repair 5.0E-07 8.0E-07 7.0E-07 4.0E-07
MLH1 mutL homolog 1 2.0E-06 4.0E-06 4.0E-06 2.0E-06
BRCA1 Breast cancer 1, early onset 2.0E-07 2.0E-07 3.0E-07 2.0E-07
EXO1 Exonuclease 1 6.0E-08 7.0E-08 1.0E-07 6.0E-08
TYMS Thymidylate synthetase 1.0E-07 1.0E-07 2.0E-07 1.0E-07
PMS2 Postmeiotic segregation increased 2 4.0E-05 8.0E-05 6.0E-05 5.0E-05
FEN1 Flap structure-specific endonuclease 1 7.0E-06 1.0E-05 1.0E-05 8.0E-06
NUDT1 Nudix-type motif 1 4.0E-05 7.0E-05 5.0E-05 5.0E-05
RAD51 RecA homolog 1.0E-07 2.0E-07 2.0E-07 2.0E-07
Apoptosis NUDT2 Nudix-type motif 2 2.0E-07 2.0E-07 1.0E-07 9.0E-08
(6610–6) CASP8AP2 CASP8 associated protein 2 2.0E-05 2.0E-05 2.0E-05 2.0E-05
ITGB3BP Integrin beta 3 binding protein 1.0E-05 2.0E-05 2.0E-05 2.0E-05
TEGT Testis enhanced gene transcript 4.0E-05 6.0E-05 5.0E-05 3.0E-05
NDUFS1 NADH dehydrogenase (ubiquinone) Fe-S 1 3.0E-06 4.0E-06 4.0E-06 3.0E-06
BNIP3L BCL2/adenovirus E1B interacting protein 3-like 4.0E-05 6.0E-05 5.0E-05 4.0E-05
SON SON DNA binding protein 4.0E-05 7.0E-05 5.0E-05 4.0E-05
CFL1 Cofilin 1 (non-muscle) 4.0E-05 6.0E-05 5.0E-05 3.0E-05
GLO1 Glyoxalase I 4.0E-08 6.0E-08 7.0E-08 4.0E-08
CHEK2 CHK2 checkpoint homolog 1.0E-08 8.0E-09 9.0E-09 1.0E-08
RNA processing TTF2 Transcription termination factor 2 2.0E-08 2.0E-08 3.0E-08 3.0E-08
(4610–8) CSTF3 Cleavage stimulation factor, subunit 3 3.0E-07 5.0E-07 5.0E-07 3.0E-07
HSPC148 Hypothetical protein HSPC148 1.0E-05 2.0E-05 2.0E-05 1.0E-05
SNRPF Small nuclear ribonucleoprotein peptide F 4.0E-05 6.0E-05 5.0E-05 4.0E-05
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PLoS ONE | www.plosone.org 4 October 2007 | Issue 10 | e1061Selected genes (by category) bound by E2F4 in all human tissues p-value for E2F4 binding
Process Gene Full Name Liver Acinar Islets HepG2
DIS3 DIS3 mitotic control homolog 4.0E-06 8.0E-06 6.0E-06 5.0E-06
SIP1 survival interacting protein 1 3.0E-05 4.0E-05 4.0E-05 3.0E-05
FTSJ2 FtsJ homolog 2 (E. coli) 3.0E-06 4.0E-06 4.0E-06 3.0E-06
CSTF2T cleavage stimulation factor, subunit 2, tau 9.0E-07 2.0E-06 1.0E-06 7.0E-07
LSM3 LSM3 homolog, U6 sn RNA associated 2.0E-06 3.0E-06 3.0E-06 2.0E-06
SFRS1 splicing factor, arginine/serine-rich 1 2.0E-07 2.0E-07 3.0E-07 2.0E-07
Organized by GO categories, top hits by significance with p-values and binding ratios.
doi:10.1371/journal.pone.0001061.t001
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Table 1. cont.
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Figure 3. Gene expression changes upon germline removal of E2f4 transcription factor binding in mouse liver, kidney, and testes are minimal,
and poorly overlap the genes bound in mice containing E2f4. (A) The complete list of genes that were differentially expressed when E2f4 was
removed where the proximal promoter of these transcripts was present on the mouse promoter array. Genes were sorted by confidence in kidney,
liver, and testes, sequentially, and the binding data then obtained separately. Most gene expression changes were tissue-specific, and very few of
these genes showed in vivo E2f4 binding. (B) The complete list of genes bound by E2f4 in kidney, liver, and testes, clustered by transcription factor
binding in each tissue sequentially. The transcripts of almost no genes bound in vivo were perturbed in the adult E2f4 null mice.
doi:10.1371/journal.pone.0001061.g003
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promoter arrays; thus, the transcriptional perturbations in adult
tissues affected by E2f4 removal during development are probably
indirect. Given the high similarity to the phenotypically normal
mice, it is reasonable to suggest that compensatory mechanisms
involving other E2f family members largely rescue the E2f4 null
phenotype. The recovery of the tissue-specific gene expression
programs underscores the well-known redundancy within the E2f-
controlled cell cycle program [1,4,5].
DISCUSSION
We have combined gene expression analysis of mice lacking E2f4
with the conservation of transcription factor binding to dissect the
conserved regulatory networks controlled by E2F4 that govern cell
cycle and proliferation in primary mouse and human tissues.
Tissue-independence of E2F4 binding and cell cycle
control
Our genome-wide analysis reveals that within a single species,
a core set of over 400 genes bound and potentially regulated by
E2F4 are largely independent of the particular tissue inspected.
High overlap between three in vitro human cell lines has been
noted previously [8,14,15]; our report confirms and extends this
result to three primary in vivo human tissues and an asynchronous
human cell line. We performed similar experiments in an even
more diverse set of primary tissues in mouse, ranging from brain to
kidney to testes, and confirmed the tissue-independence of E2f4
binding in a second species. Because every primary tissue contains
different sets of transcription factors, chromatin remodelers, and,
indeed, chromatin structures, the presence of a commonly bound
set of genes that makes up the large majority of E2F4 binding
targets in multiple human (or mouse) tissues suggests that this key
member of the DREAM complex binds independently of the
above factors. Furthermore, the high overlap of E2F4 bound genes
in the diverse human tissues we characterized indicates that the
regulatory mechanisms used by the DREAM complex to control
entry into cell cycle in human glioblastoma cells are likely
employed in all human tissues [8]. Consistent with this, as
expected the target genes shared commonly among multiple
tissues in each species are functionally enriched in cell cycle, DNA
repair, and DNA replication.
Conservation of a binding event between mouse
and human enriches functionally relevant genes
We took advantage of the genome-wide nature of our data in
mouse and human to identify how conserved E2F4 binding is
among the approximately five thousand homologous genes present
on both microarrays. This approach revealed two key findings
regarding how E2F4 controls cell cycle and proliferation via
genomic binding. First, we found that less than a quarter of genes
bound by E2F4 in one species were bound in the second. Our
observation that E2F4 binding within a particular species is largely
insensitive to tissue-specific binding partners and overall chroma-
tin state makes the modest conservation of E2F4 binding events
between species all the more remarkable. It has been suggested
that the interaction of different members of the DREAM complex
(e.g. E2f4 and p107) may vary between mouse and human;
a variation that may have functional implications for E2f4’s role in
mouse [27]. Thus, one possible explanation is that variability with
the composition and/or stoichiometry of the DREAM complex
between mouse and human that is specific to each species may
direct the complex to different sets of targets.
Second, a feature of the approximately fifty genes where E2F4
binding is conserved is their remarkable enrichment in cell cycle,
proliferation, and DNA repair functions. This result is consistent
with the hypothesis that when a transcription factor binding event
is conserved, this conservation is a good indictor of a functional
regulatory connection [23]. We predict that comparing genomic
occupancy of a transcription factor in divergent species will be
useful in general as a strategy to identify direct transcription factor
targets.
Cell cycle programs and tissue-specific transcription
We expected that removal of E2f4, as a key member of the
DREAM complex would have profound implications for the
correct gene expression of the genes bound by E2f4 in vivo.
Instead, however, we found that developmental recovery and
survival to adulthood corresponds with almost completely normal
gene expression in multiple tissues, relative to their phenotypically
normal heterozygous littermates. Given the substantial develop-
mental defects described above, the subtle and limited changes in
the gene expression profiles of E2f4 null tissues is nevertheless
surprising, despite the largely normal physiology of these mice in
adulthood. It has been known since the report of viable E2f4 null
mice that the function of most tissues, even those directly impacted
during development by absence of E2f4, recovers. Our findings
reveal that this recovery extends to the level of gene expression; it
appears that the absence of E2f4 can have profound, yet
remarkably transient, implications for tissue-specific transcription-
al programs. This recovery almost certainly depends on the
overlapping roles that other members of the E2f family can play.
For instance, it has been previously shown that E2F5 can largely
compensate for the absence of E2F4 in vivo [22]. Fully
understanding the complementary and often overlapping roles
the E2f family play will require genomic and genetic dissection of
genetically modified mice combinatorially lacking multiple E2f
family members, using approaches such as those reported here.
Our results also provide direct support to the hypothesis that
transcriptional binding is often neutral in nature [29]. Notably, the
perturbed genes did not overlap significantly with E2F4 bound
genes, and inspection of the perturbed sets of genes revealed no
substantial functional category enrichment (including cell cycle and
proliferation), thereby suggesting that these perturbations are not
directly caused by removal of E2F4. Further supporting this
observation, we found no enrichment of the canonical E2F4 binding
sequence in the proximal promoter regions upstream of the genes
perturbed by removal of E2F4. Taken together, it appears that E2F4
has a substantial number of binding events that are entirely
dispensable for proper transcription of downstream genes, despite
the well-characterized role it plays in cell cycle control.
Conclusion
We have used comparative genomics approaches to explore the
evolutionarily conserved regulatory pathways that E2F4, a key
member of the DREAM complex, uses to maintain control of gene
expression programs. We find that that most genes bound by E2F4
are common to numerous primary tissues within a species. This
suggests that the regulatory architecture controlling quiescence
may be similar among tissues that have remarkably different
capacities for re-entry into the cell cycle. Understanding this
architecture will require further studies to explore how E2f4 acts
within specific cell types during development. The striking and
specific conservation of E2F4 binding between mouse and human
at cell cycle and proliferation genes suggests that only the targets
crucial for the function of the DREAM complex are under
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has at best modest effects on gene expression programs
dramatically underscores the well-known redundancy within cell
cycle regulation. Our study demonstrates the power of using the
conservation of transcription factor binding at orthologous mouse-
human genes as a tool to identify regulatory connections that
appear to be under evolutionary pressure.
MATERIALS AND METHODS
Reagents and antibodies
All chemicals were purchased from Sigma-Aldrich, and used as
received unless otherwise noted. E2F4 antisera were obtained from
Santa Cruz Biotechnology (polyclonal, rabbit, sc-1082) and used
as described in prior studies [15,27], or were created in the J. Lees
laboratory (monoclonal mouse antisera LLF4-1) [30]. Data
accession numbers at ArrayExpress are: E-TABM-272 and E-
MEXP-1131.
Mouse tissues for chromatin immunoprecipitation
Mice used in chromatin immunoprecipitation experiments were
F1 males from a B6/C57 male cross with an A/J female (Jackson
Laboratories). Islets suitable for ChIP studies were isolated by
standard techniques and hand picking at Joslin Diabetes Center on
mixed gender mice of the same genetic background (B6/C57xA/
J). Other tissues were harvested using standard techniques, soaked
or perfused with 1% formaldehyde, and homogenized in
neutralization buffer followed by ChIP. For expression studies,
E2f4 2/2 homozygous and E2f4 +/2 heterozygous knock-out
mice were derived in a B6/C57 and 129S2/SvPas cross
background [16,31].
Human tissues
Primary human hepatocytes were obtained from the Liver Tissue
Procurement and Distribution Program (NIDDK contract num-
ber N01DK92310) at the University of Pittsburgh. Human
pancreatic islets and pancreatic acinar tissues were the kind gifts
of Gordon Weir, Abdulkadir Omer (Joslin Diabetes Center) and
Nicolas Benshoff (University Minnesota) (NIDDK contract
numbers NCRR ICR U4Z RR16606; U19DK6125).
Mouse mRNA preparation for gene expression
studies
Mouse tissues were harvested from two E2f4 2/2 and two E2f4
+/2 heterozygous littermates [16]. After organ removal, the
tissues were homogenized, and the cells resuspended into Trizol
with nuclease inhibitors. Corresponding mRNA from homozy-
gotes and heterozygotes was obtained, normalized in concentra-
tion, and hybridized as biological duplicates to Affymetrix 430A
Genome arrays using standard methods.
Analysis of gene expression
The limma [26] and affy [32] packages within the R environment
[33] were used to pre-process the array intensities and identify
differentially expressed (DE) genes. The quality of the arrays was
checked using exploratory data analysis methods [34]. Boxplots
and density plots of unprocessed log-scale probe intensities were
compared across arrays, and RNA digestion plots showing the 39/
59 intensity ratios were used to check for similar rates of RNA
degradation across arrays. Further quality diagnostics were based
on the fit of a probe level model to the data, implemented using
the affyPLM package [35], which models the dependence of
probeset intensities on the probes and the array using robust
regression procedures [36]. Chip pseudo-images of the signed
residuals from the regression were plotted to check for spatial
artifacts which may not appear in the raw-data image plots and
plots of the Normalized Unscaled Standard Errors compared the
fit of each array. Based on these quality checks, all arrays were
retained for subsequent analysis. The probesets were then
normalized and summarized using the Robust Multichip Average
method RMA [37]. A linear model including empirical Bayes
smoothing [26,38] was fitted to the pre-processed data for all
arrays to obtain moderated t-statistics (and B-statistics) corre-
sponding to the contrast between heterozygous and E2f4 2/2 for
each tissue. The Benjamini-Hochberg correction BH [39] was
applied to the p-values (corresponding to the moderated t-statistics)
to give values adjusted for multiple testing across genes. By visual
inspection of volcano plots, adjusted p-values of 0.05 were used to
obtain sets of DE genes between E2f4 heterozygous and
homozygous knock out mice. Permutation tests were used to
check for systematic up-regulation or down-regulation of the genes
bound by E2f4 in all tissues (as identified from the Microarray
Analysis explained below). The permutation test is a simple non-
parametric method for comparing the distributions of two sets, in
this case the genes bound by E2F4 whose expression was analyzed,
and the corresponding unbound genes.
Chromatin immunoprecipitations
The procedure for chromatin immunoprecipitation has been
reported previously [8,14,40]. Briefly, mice were sacrificed at 8–
12 weeks and the following tissues were harvested: Brain, kidney,
liver, pancreatic islets, pancreatic acinar, spleen, and testes. Both
mouse and human tissues were treated with formaldehyde to
covalently link transcription factors to DNA sites of interaction by
either immersion in, or perfusion with 1% final concentration
formaldehyde, followed by homogenization using a manual glass
cell homogenizer. Chromatin in cell lysates was sheared by
sonication at 4uC using a Misonix 3000 sonicator with power
output set at 27–30 watts for ten 30-second pulses with one minute
break intervals. The transcription factor-DNA complexes were
enriched by chromatin immunoprecipitation, the cross-links
reversed, and enriched DNA fragments and control genomic
DNA fragments amplified using ligation-mediated PCR. The
amplified DNA preparations, labeled with distinct fluorophores,
were mixed and hybridized onto a promoter array with yeast
tRNA and COT1 mouse or human DNA as non-specific carrier
nucleic acids. A human genomic array (Hu19K) consisting of PCR
products representing 19,000 proximal promoters was constructed
to capture 1 KB of sequence immediately upstream of the
transcription start sites (TSS) [15,40]. In addition, the Hu19K
array has additional coverage of 7 kb around the TSS of 200
transcription factors using 1 kb PCR fragments, as well as 4 kb
coverage using 1 kb PCR fragments around all 250 known human
microRNA loci. A similar mouse genomic array (Mm13K) was
also used that represents 13,000 promoter regions, and coverage of
mouse microRNA loci similar to the human array [41].
ChIP-chip microarray analysis
The statistical analysis was performed using the limma package.
Quality of the arrays was assessed using array images of the
background and foreground intensities and also of the red/green
(Cy5/Cy3) ratios to check for spatial artifacts. MA-plots (log-fold
change against average log-intensity for each gene) [42] were used
to compare different replicates for each tissue and the arrays that
were most consistent with respect to quality and intensity levels
were used for downstream analysis. The distribution of log-ratios
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and background correction). However, the scale variation was not
observed to be associated with tissue type; rather the variation
appeared to be more likely due to IP efficiency differences between
individual experiments. The conclusions could only be reached
because enough replicates were available for each tissue. Likewise,
the replicates allowed sensible quality assessment and the best two
arrays for each mouse tissue and three arrays for each human
tissue were selected for subsequent analyses. Given the assumption
that the log-ratio distributional differences were not associated
with tissue type, the data were scale normalized between arrays
using quantile normalization of the log-ratios (rather than a robust
scale normalization, such as MAD scaling). Due to the one-probe-
per-gene nature of the proximal promoter arrays, modified t-
statistics were used to identify the probes that were enriched
(bound) in each tissue. The corresponding BH adjusted p-values
were used to correct for multiple testing across genes, and the
results were visualized using volcano plots. Two thresholds were
chosen by visual inspection of the volcano plots to define sets of
binding sites of varying stringency for each tissue. To create lists of
tissue-specific binding events, we used the stringent cut-off
(adjusted p-value 10
24). The set of commonly bound genes was
defined using the less stringent value of 10
23, to capture binding
events falling just under the more stringent threshold in one or two
tissues. To find orthologous mouse and human genes on the
promoter arrays, gene symbols and accession numbers were linked
to the Ensembl IDs for each species to match the two gene lists.
The data in [15] were analyzed using the same pipeline described
above for our data; binding sites were identified using an adjusted
p-value of 10
24. The comparison with Litovchick ChIP data was
done by comparing their published binding results to the cut-offs
described in Figure S2 [8].
Analysis of Gene Ontology GO categories
We determined the enrichment of functional categories among the
bound gene sets using the GOstat tool [43], which detects
significant enrichment of GO categories in a specific set of genes
compared to the whole set of genes present on the array for each
species. The method exploits Fisher’s Exact Test to produce BH
multiple-testing corrected p-values showing whether each GO
term that appears in the selected group of genes is over-
represented or under-represented.
Analysis of the presence of E2F4 binding sequence
Given the sequences of the promoters on the ChIP array, a Perl
script was used to automate BLAST searches of alignment across
the genome and screen the BLAST output and BioPerl was used to
extract the genomic coordinates of the promoters. To interrogate
for the presence of the E2F4 motif, we used the one-kilobase E2F4
bound regions plus an additional 300 bases upstream and
downstream to account for the resolution of the ChIP technique
[41]. We used the E2F4 binding sequence as derived by [41],
based on the positional weight matrix model [44] of binding
specificity. The enrichment score of the presence of the binding
motif was equivalent to the log-likelihood of these probabilities,
and the threshold used was based on the possible maximum scores
for each promoter. To confirm that the binding sequence results
were not dependent on the particulars of the thresholds chosen, we
chose a stringent threshold of 10.6 for the enrichment scores as
well as a more lenient value of 10.0 (Supplemental Figure 4). To
judge whether the E2F4 binding sites identified by our previous
analysis had a significant over-representation of the E2F4 motif,
the hypergeometric distribution was used to find the probabilities
that those genes could have been randomly sampled from the
genes on the promoter array. Based on the hypothesis of
independence between the identified genes and the presence of
the motif, the calculated p-values show the probability of the motif
appearing in as many or more promoters as observed, compared
to the background motif presence.
Distance of E2F4 binding events to nearest
transcriptional start site
Human E2F4 ChIPs in primary human liver were hybridized in
duplicate to human whole chromosome 21 microarrays; mouse
E2f4 ChIPs in primary mouse liver were hybridized in duplicate to
mouse whole chromosome 16 microarrays (Agilent AMADID
numbers 014841 and 015340, respectively). The limma package
within R was used in the genomic microarray data analysis.
Quality assessment included boxplots and images of the back-
ground and foreground intensities for both red (Cy5) and green
(Cy3) channels, as well as MA-plots. All the arrays used in the
analysis exhibited good quality. Expression red/green log-ratios
were median-normalized, after background subtraction, within
each array. E2F4 binding events were empirically assigned as
minimum contiguous regions comprising, at least, one probe for
which the red/green ratio was greater than 5, or two adjacent
probes with ratios greater than 2.5 and a combined (summed) ratio
greater than 6.5, or three adjacent probes with ratios greater than
2 and a combined (summed) ratio greater than 9. A Perl script was
used to compute the genomic base pair distance between each
binding event and the closest transcription start site. Transcrip-
tomic annotation relied on tables downloaded from the UCSC
Genome Browser server. The smoothed histograms in Figure S1
were generated in R by applying the density function (default
parameters) to the distance distributions and plotting the re-
spective outcomes.
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